JAN (NYSE:JAN) Releases Earnings Results, Beats Estimates By $0.01 EPS

JAN (NYSE:JAN) announced its earnings results on Monday. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01, Zacks reports. The business had revenue of $268.30 million for the quarter.

JAN Stock Performance

Shares of JAN traded down $0.06 on Monday, hitting $28.46. 2,289,133 shares of the stock traded hands, compared to its average volume of 1,505,174. JAN has a 1 year low of $22.76 and a 1 year high of $32.83. The stock’s 50 day moving average is $29.68 and its two-hundred day moving average is $28.02.

JAN Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, December 29th. Investors of record on Friday, December 18th will be paid a dividend of $0.0475 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $0.57 annualized dividend and a dividend yield of 2.0%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Readystate Asset Management LP purchased a new stake in shares of JAN in the second quarter valued at $1,724,000. Engineers Gate Manager LP acquired a new position in JAN in the second quarter valued at $15,274,000. Wellington Management Group LLP purchased a new position in JAN during the second quarter worth about $8,739,000. Asset Management One Co. Ltd. lifted its position in JAN by 1,764.5% during the third quarter. Asset Management One Co. Ltd. now owns 130,326 shares of the company’s stock worth $3,862,000 after buying an additional 123,336 shares during the period. Finally, WINTON GROUP Ltd purchased a new position in JAN during the second quarter worth about $2,985,000. 6.27% of the stock is currently owned by institutional investors and hedge funds.

JAN News Roundup

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Adjusted funds from operations (FFO) increased 46% year over year to $0.25 per share, exceeding the $0.24 consensus estimate. Janus Living quarterly results
• Positive Sentiment: Revenue rose 78% year over year to approximately $268 million, indicating strong portfolio growth and increased operating scale. Janus Living reports third-quarter results
• Positive Sentiment: Management increased its full-year 2026 guidance, a potentially favorable signal for future earnings and cash-flow expectations. Janus Living guidance update
• Positive Sentiment: Mizuho initiated coverage with an “outperform” rating and a $33 price target, above the referenced $28.46 share price, implying meaningful potential upside. Mizuho Janus Living rating
• Neutral Sentiment: Janus Living reported a net loss of $0.02 per share, so investors may continue to monitor profitability despite the improvement in adjusted FFO and revenue.

Analyst Upgrades and Downgrades

JAN has been the topic of a number of analyst reports. Zacks Research lowered shares of JAN from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 20th. Royal Bank Of Canada increased their target price on shares of JAN from $30.00 to $34.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Scotiabank lifted their price target on shares of JAN from $31.00 to $33.00 and gave the company a “sector outperform” rating in a research report on Thursday, September 17th. Barclays decreased their price target on JAN from $34.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 13th. Finally, Compass Point assumed coverage on JAN in a report on Wednesday, September 16th. They issued a “neutral” rating and a $37.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.35.

About JAN

JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.

Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.